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Abstract
In this paper we propose an ecological resilience point of view on cancer. This view is
based on the analysis of a simple ODE model for the interactions between cancer and normal
cells. The model presents two regimes for tumor growth. In the first, cancer arises due to
three reasons: a partial corruption of the functions that avoid the growth of mutated cells, an
aggressive phenotype of tumor cells and exposure to external carcinogenic factors. In this case,
treatments may be effective if they drive the system to the basin of attraction of the cancer cure
state. In the second regime, cancer arises because the repair system is intrinsically corrupted.
In this case, the complete cure is not possible since the cancer cure state is no more stable, but
tumor recurrence may be delayed if treatment is prolongued. We review three indicators of the
resilience of a stable equilibrium, related with size and shape of its basin of attraction: latitude,
precariousness and resistance. A novel method to calculate these indicators is proposed. This
method is simpler and more efficient than those currently used, and may be easily applied
to other population dynamics models. We apply this method to the model and investigate
how these indicators behave with parameters changes. Finally, we present some simulations
to illustrate how the resilience analysis can be applied to validated models in order to obtain
indicators for personalized cancer treatments.
Keywords : Tumor growth; Chemotherapy; Basins of Attraction; Regime shifts; Critical transi-
tions.
1 Introduction
The ecological resilience perspective is an emerging approach for understanding the dynamics
of social-ecological systems [1, 2, 3, 4, 5, 6]. While the stability point of view emphasizes the
equilibrium and the maintenance of present state, the resilience point of view focus on shifts
between alternative basins of attraction, thresholds, uncertainty and unexpected disturbances.
External forces or random events may cause state variable perturbations that drive a nonlinear
system, which is initially near a stable state, to enter an undesirable basin of attraction. In this
case, the resilience of the original steady state is related with the size and shape of its basin of
attraction, and the capacity of the system to persist in this basin of attraction when subject
to state variable perturbations. Three different indicators are established in the literature as
measures of the resilience of a stable state with respect to state variable perturbations [7, 8]:
latitude, which is a measure of the volume of its basin of attraction; precariousness, which is
related with the minimal state space disturbance needed to drive the system outside its basin
of attraction; and resistance, which is a measure of the deepness of its basin of attraction.
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On the other hand, changes in system parameters occur in a slow time scale, due to evolu-
tionary forces or by modifying the intensities of interactions and forces governing such system.
In this case, parameters modify the resilience of the system with respect to state variable
perturbations. Further, when parameters do change enough, the system may undergo several
bifurcations and the phase portrait may change substantially. In this case, one can measure
the resilience of the system with respect to parameters changes as the distance to the thresh-
old values for which bifurcations occur. As a consequence of such bifurcations, an undesirable
alternative stable state may be created, and its basin of attraction can be achieved by state
variable perturbations, as commented above. A more dramatic outcome happens when param-
eters changes lead to loss of stability of the original steady state or even its disappearance. In
this case, a regime shift occurs and the system moves to another state. Now, the question of
reversibility takes place. Of first importance is the question whether it is possible or not to
return the parameters to their original values. When parameters change due to evolutionary
factors, it is more likely that this change can not be undone. Changes due to external forces can
be undone more easily through the correct manipulation of those forces (if possible). However,
even if the original values can by restored, the reversal to the original stable state may not be
completely achieved if the system exhibits hysteresis.
In this paper we illustrate how these concepts of ecological resilience can be applied to cancer,
a complex disease whose causes are far from being well understood and whose cure is far from
being achieved. Indeed, despite the intense efforts that led the elucidation of many biochemical
mechanisms developed by cancer cells to survive [9], there is a current debate on which are
the major factors that allow the onset of cancer cells. While some argue that alterations in
intrinsic cellular processes are the main reasons that some tissues become cancerous [10], others
defend the view that most cases of cancer result from extrinsic factors such as environmental
exposure to toxic chemicals and radiation [11]. With respect to cancer treatment, although
the development of new drugs and strategies to treat cancer in the last fifty years achieved
good results in many cases, another large portion of cancer patients did not respond well to
treatments, or presented tumor recurrence, indicating that there is still a long road in the fight
against cancer [12, 13].
We propose a simple model for tumor growth and apply the above concepts to suggest a
framework for viewing the arising of cancer and its effective treatment as critical transitions
between two alternative stable states. In this framework, tumor growth and tumor treatment
depend ultimately on ecological resilience questions. Further, we briefly review the three re-
silience indicators commented above, propose a method to calculate these indicators and apply
this method to the model. As far as we know, this novel method we propose is simpler and more
efficient than those currently used, and can be applied to other population dynamics models to
improve their analysis through this resilience perspective.
The paper is organized as follows. In Section 2 the model is presented. In Section 3 the
analysis of the model is performed. In Section 4, the results are discussed in the ecological
resilience perspective. In Section 5, the method to calculate resilience indicators is presented
and applied to the model. Finally, conclusions are presented in Section 6.
2 A toy model for tumor growth
We present a simple model consisting of a system of ODEs describing tumor growth and its effect
on normal tissue, together with the tissue response to tumor. Our goal is not to consider the
several aspects of tumor growth and to reproduce quantitative behavior with high accuracy, but
to use the model to give some insights through a resilience point of view. The model equations
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are given by
dN
dt
= rN − µNN − β1NA, (1a)
dA
dt
= rAA
(
1− A
KA
)
− β3NA− (µA + A)A, (1b)
where N and A stand for normal and tumor cells, respectively. This system is a limit case of a
three-dimensional model for oncogenesis encompassing mutations and genetic instability [14].
Parameter rN represents the total constant reproduction of normal cells, and µN is their
natural mortality. A constant flux for normal cells is considered in the vital dynamics, and not
a density-dependent one, like the logistic growth generally assumed [15, 16, 17, 18]. The reason
for this choice is that at a normal and already formed tissue the imperative dynamics is not
the cells intraspecific competition by nutrients, but the maintenance of a homeostatic state,
through the natural replenishment of old and dead cells [19].
On the contrary, cancer cells have a certain independence on growth signals released by
the tissue and keep their own growth program, like an embrionary tissue in growth phase [20].
Thus a density dependent growth is considered. Several growth laws could be used, such as the
Gompertz, generalized logistic, Von Bertanlanfy and others [21]. We choose the logistic growth
due to its simplicity, and a natural mortality µA. An extra mortality rate A due to apoptosis
[22] is also included.
Several models for tumor growth consider the phenomena of tumor angiogenesis, i.e., the
formation of new blood vessels to feed the tumor, in response to signals released by tumor cells
[23, 24]. In order to keep the model as simple as possible, we do not consider angiogenesis here.
Parameter β3 encompasses, in the simplest way, all negative effects imposed to cancer cells
by the many cell types in the normal tissue. These interactions include the release of anti-
growth and death signals by host cells [9], the natural response of normal cells to the presence
of cancer cells, the competition by nutrients with tumor cells and so on. Similarly, parameter β1
covers all mechanisms developed by tumor cells which damage the normal tissue, like increasing
local acidity [25], supression of immune cells [26], release of death signals [9], and competition
with normal cells.
System (1) is similar to the classical Lotka-Volterra model of competition [27], commonly
used in models for tumor growth [15, 16, 17, 18] and biological invasions [28], but has a funda-
mental difference. The use of a constant flux instead a logistic growth to normal cells breaks the
symmetry observed in the classical Lotka-Volterra model, so that no equilibrium with N = 0
will exist. Thus, normal cells will never be extinct, on the contrary to those models. We be-
lieve that this is not a problem, but, on the contrary, is a realistic outcome. Indeed, roughly
speaking, cancer ‘wins’ not by the fact that it kills all cells in the tissue, but by the fact that
it reaches a dangerous size that disrupts the well functioning of the tissue and threaten the
health of the individual. A constant flux term was already taken in other well-known models
for cancer, specifically, to describe the growth of immune cells [29, 30, 31].
Let us comment on some resemblance of system (1) with the well-known system of Kuznetsov
et. al [29], which describes the interaction between immune cells and cancer cells. In that
system, equation for immune cells has two production terms: a constant production term
(analog to rN here) and a Michaelis-Menten term representing the recruitment of immune cells
due to the presence of cancer cells. If we remove this second term (letting p = 0 in their
notation), that system becomes equivalent to system (1). Thus, the immune cells of that model
have basically the same behavior of normal cells in this model, and the unique difference is the
recruitment term. In our model, as the population N is considered as a pool of many different
cell types, from which the immune cells are a small fraction, it is natural to include in its
dynamics only the common behavior of all these types, disregarding the particularities of each
type.
3
3 Analysis of the model
We now present the analysis of system (1). Biological implications are discussed in Section 4.
3.1 Equilibrium points
System (1) has a trivial equilibrium
P0 =
(
rN
µN
, 0
)
,
and up to two nontrivial equilibria
Pi = (Ni, Ai) =
(
rN
µN + β1Ai
, Ai
)
, i = 1, 2.
Here, A1 and A2 are the roots of the second degree equation
aA2 + bA+ c = 0, (2)
with coefficients
a =
β1rA
KA
> 0, b = lA
(
βth1 − β1
)
, c = rN
(
β3 − βth3
)
.
where
βth1 =
µNrA
lAKA
, βth3 =
µN
rN
lA, and lA = rA − (µA + A). (3)
When A1 and A2 are real, we label them in the order A1 < A2. Conditions for having posi-
tive equilibria P1 and P2 are obtained by Descartes’ Rule of Signs. Together with the trivial
equilibrium P0, the results are summarized as follows:
I) If β3 > βth3 and β1 < βth1,∆, the unique nonnegative equilibrium is the trivial equilibrium
P0.
II) If β3 > βth3 and β1 > βth1,∆, three nonnegative equilibria are P0, P1 and P2.
III) If β3 < βth3 , the nonnegative equilibria are P0 and P2.
The threshold βth1,∆, defined for β3 > βth3 , is the value of β1 > βth1 for which the discriminant
∆ = b2 − 4ac is zero, and is given by
βth1,∆ = β
th
1 + 2η + 2
√
η(βth1 + η), (4)
where η = rArN(β3 − βth3 )/(KAl2A).
The threshold βth3 can be written as βth3 = lA/N0, where N0 = rN/µN is the number of
normal cells in the absence of tumor cells. As we will see, condition β3 > βth3 implies on more
difficult regimes for cancer to arise. Thus, favorable regimes for tumor growth occur for larger
values of net reproduction rate lA of tumor cells and for smaller values of carrying capacity of
normal cells N0. The threshold βth1 for tumor aggressiveness increases as the mortality µN of
normal cells increases, and decreases as the effective carrying capacity of tumor cells lAKA/rA
increases.
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3.2 Local Stability
Stability of P0 is easily determined. The eigenvalues of the Jacobian matrix of system (1)
evaluated at P0 are given by
λ1 = −µN , and λ2 = rN
µN
(βth3 − β3).
Thus, P0 is locally asymptotically stable if β3 > βth3 , and is a saddle otherwise.
We now study the local stability of Pi, i = 1, 2. Using the fact that Ni and Ai satisfy
lA − rA
KA
Ai − β3Ni = 0, (5)
we find that the Jacobian matrix of system (1) evaluated at Pi is given by
J(Pi) =
[
−β1Ai − µN −β1β3 (lA − rAKAAi)−β3Ai − rAKAAi
]
.
Whenever Pi is a positive equilibrium, the trace of J(Pi) is negative. Thus, when Pi is positive,
both eigenvalues of J(Pi) will have negative real part if det(J(Pi)) > 0, and we have opposite
signs in the other case. Calculating the determinant we obtain
det(J(Pi)) = Ai
(
2
β1rA
KA
Ai +
µNrA
KA
− β1lA
)
= Ai(2aAi + b),
where a and b are the coefficients of (2). We have that A1,2 = (−b ±
√
∆)/2a, with A1 < A2,
where ∆ is the discriminant of (2). Thus, whenever Pi is a positive equilibrium, i = 1, 2,
det(J(P1)) = −A1
√
∆ < 0, and det(J(P2)) = A2
√
∆ > 0.
Thus, P1 will be a saddle point whenever it is positive (case II above), and P2 will be stable
whenever it is positive (cases II and III above).
3.3 Asymptotic behavior and global stability
Let us show the boundedness of trajectories of (1). By noting that
dN
dt
≤ rN − µNN,
and
dA
dt
≤ lAA
(
1− rA
lAKA
A
)
,
we may apply classical comparison principles [32] and conclude that all solutions (N(t), A(t))
with non-negative initial values remain restricted in the box
B =
[
0,
rN
µN
]
×
[
0,
lA
rA
KA
]
(6)
when t→∞.
In order to rule out periodic orbits for system (1) we apply the Dulac Criterion [33] with
u(N,A) = 1/NA, obtaining
∇ ·
(
1
NA
(
dN
dt
,
dA
dt
))
= −rANA+KArN
KAAN2
< 0
5
for (N,A) ∈ B. Thus, system (1) has no periodic orbits.
By the Poincaré-Bendixson Theorem we conclude that all trajectories converge to an equi-
librium point [33]. It implies that equilibria P0 and P2 are globally stable in cases I and III,
respectively (in the latter, P2 is globally stable for initial conditions A(0) > 0, since the N axis
is the stable manifold of P0). In case II, the plane N×A is divided in the basins of attraction of
P0 and P2. The stable manifold of P1 is the separatrix between these basins. All these results
are summarized in Theorem 1.
Theorem 1. System (1) has the following behavior:
I) If β3 > βth3 and β1 < βth1,∆, then P0 is globally stable.
II) If β3 > βth3 and β1 > βth1,∆, then P0 and P2 are locally stable. Equilibrium P1 is a saddle
point whose stable manifold is the separatrix between the basins of attraction of P0 and
P2.
III) If β3 < βth3 , then P2 is globally stable for initial conditions A(0) > 0.
The division of the β1 × β3 plane into regions I, II and III is showed in Figure 1.
β1=β1,Δth orβ3=β3,Δth
SN(P1,P2)
TC(P0,P1)
TC(P0,P2)
I: P0 GASIII: P2 GAS
II: P0 and
P2 LAS
b ca β3th β3
ii
i
β1th
β1
Figure 1: Left: Regions I, II and III in the β3 × β1 plane of parameters space, together
with equilibria behavior. If β1 < βth1 , a direct transition from III to I occurs as β3 increases,
with a transcritical bifurcation between P0 and P2 when β3 = βth3 . If β1 > βth1 , a transition
from III to II and a transcritical bifurcation between P0 and P1 occurs at β3 = βth3 ; a second
transition, from II to I, occurs when β3 = βth3,∆, with a saddle-node bifurcation between P1 and
P2 (for an expression and details about βth3,∆, see Section 4.1). Right: bidimensional diagram of
the A coordinates of equilibria P2 (red, stable), P1 (orange, unstable) and P0 (blue, stable for
β3 > β
th
3 ), when β3 and β1 vary.
3.4 Numerical simulations
We now present numerical simulations in order to stimulate discussions in next sections. Figure
2 shows simulations of system (1) in cases II and III. Parameters values were based on data
from the literature, specially for breast cancer, according to the procedure below. A summary
of the parameter values is presented in Table 1.
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Figure 2: Solutions os system (1) when parameters correspond to regimes II (A) and III (B),
using values in Table 1. Initial conditions are N(0) = rN/µN −A0 and A(0) = A0, representing
that the tissue was initially at its homeostatic state when A0 cells have become cancerous. The
values of A0 are: (A) A0 = 0.06 × 108 cells and A0 = 0.07 × 108 cells; (B) A0 = 1 cell and
A0 = 0.07×108 cells. In the left panel, the gray dotted curve represents the separatrix between
the basins of attraction of P0 and P2. The green and blue numbers indicate the time (in years)
corresponding to the trajectory.
Table 1: Parameters description and values adopted in simulations.
Parameter Description Value
µN 1/µN is the lifetime of a normal cell 0.01 day−1
rN total constant reproduction of normal cells 106 cell day−1
rA tumor cells growth rate 0.05 day−1
KA tumor carrying capacity 0.75× 108 cells
µA natural mortality rate of cancer cells 0.01 day−1
A extra mortality rate of cancer cells 0.01 day−1
β1 cancer cells aggressiveness 0.40× 10−9 cell−1day−1
βII3 tissue response to cancer cells - case II 0.28× 10−9 cell−1day−1
βIII3 tissue response to cancer cells - case III 0.32× 10−9 cell−1day−1
We assume that the lifetime of a normal cell is 100 days, thus µN = 1/100 days−1. The
number of normal cells in the breast cannot pass N0 = 108 cells [34]. Thus, in order to adjust the
equilibrium rN/µN of normal cells in the absence of cancer to be 108 cells, we consider rN = 106
cells/day. For cancer cells, we assume the same natural mortality, µA = 1/100 days−1. For
the apoptotic rate of A cells, we use A = 1/100 days−1. The ratio birth rate/death rate is 1
for a normal tissue, in order to maintain a homeostatic state. Following [34], we assume that
cancer cells have increased this ratio by a factor of five. Thus, we have rA = 5/100 days−1. In
order to have the maximum number of cancer cells being 75% of the normal cells, we consider
KA = 7.5 × 107. The values of interacting parameters β1 and β3, in units of cell−1day−1, are
unknown a priori but, by substituting the values of other parameters, we obtain the thresholds
for β1 and β3: the threshold βth3 which separates cases II and III has the value βth3 = 0.30×10−9.
So, we assume two possible values for β3: βIII3 = 0.28 × 10−9, and βII3 = 0.32 × 10−9. Each
of these values will originate a different behavior of system (1) (see Figure 1). If β3 = βIII3 we
are in case III, for every value of β1. If β3 = βII3 , we have βth1,∆ = 0.37 × 10−9, so we assume
β1 = 0.40 × 10−9 > βII3 , which is reasonable since cancer cells are supposed to cause more
damage to normal cells than the contrary. With these values we are in case II. In all numerical
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simulations in this paper, we use these parameter values, and β3 = βIII3 or β3 = βII3 , depending
on the interest to simulate cases III or II.
4 An ecological resilience perspective on cancer
We now discuss the biological implications of the previous analysis. Our look to system (1)
as being a simple cartoon, a toy model of the underlying system governing tumor growth in a
cancer patient and thus we apply the perspective of ecological resilience to discuss the above
results. Although this is a rough approximation, it may be instructive illustration on our
understanding of cancer onset and cancer treatment. By cartoon or an approximation, we
mean that the underlying system of cancer in real life, despite being very complex, may present
three qualitative distinct regimes, corresponding to regimes I, II and III of system (1). In this
analogy, an equilibrium state corresponding to the presence of a tumor is not necessarily a
static equilibrium, but a state of the system where a tumor is growing and developing. Let us
discuss the differences between these regimes.
4.1 Cancer onset as a critical transition
Initially, we look to cancer onset as a critical transition. Let us first comment on the ‘natural
repair system of the patient’, a mechanism which is operated at a variety of levels and by many
agents. In the tissue level, it is operated by the immune system, through lymphocytes and
natural killer cells for example [35]. The presence of cancer cells at a given site stimulate the
locomotion of immune system cells to that site in order to eliminate the cancer cells. At the
cellular level, many cell components watch some parameters of the own cell and its neighbors,
as DNA integrity, the products of cellular metabolism, the concentration of growth factors,
etc. When abnormal conditions are detected, the cell may kill itself through apoptosis [22],
or the normal cells may release death or inhibitor factors to control the undesired growth [9].
In system (1), these mechanisms are roughly described by parameters β3 and A. These are
the parameters most subject to changes in a slow-time scale, through the multistep process
of genetic alterations which transform the descendants of a normal cell into a malign tumor
[9]. Parameter β1 is also thought to be a varying parameter in this slow-time scale, since it
encompasses the many types of negative interactions which cancer cells impose to the host
tissue, especially due to changes in their metabolism which increase local acidity or lead to
starvation of oxygen and nutrients for normal cells.
In the first regime (region I), we have a healthy person, since P0 is globally stable. In this
case, we have an efficient tissue repair system, since condition β3 > βth3 can be written as
β3 + A
µN
rN
>
µN
rN
(rA − µA).
Further, we have a limited aggressiveness of cancer cells, β1 < βth1,∆. This condition depends
also on β3, because βth1,∆ depends on β3 (see Figure 1, left). Therefore, for a fixed β1, condition
β1 < β
th
1,∆ is equivalent to β3 > βth3,∆, where βth3,∆ is the inverse function of βth1,∆. Thus, for
each level of aggressiveness of cancer cells, i.e., for each fixed β1, we have a second threshold,
βth3,∆, that the tissue response β3 must be above in order to completely eliminate the chance of
cancer. The more aggressive are the cancer cells, the higher is the threshold βth3,∆. Thus, region
I corresponds to parameters such that, although new mutant cells may arise all the time, they
are not so much aggressive and the intrinsic repair system is capable to eliminate them.
In the second regime (region II), we have the possibility of having cancer, since P0 and P2
are both stable. Condition β3 > βth3 implies that the tissue response is efficient, but condition
β1 > β
th
1,∆, which is equivalent to β3 < βth3,∆, implies that this response is not completely capable
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to face the aggressiveness of cancer cells. Thus, region II corresponds to a partially corrupted
repair system due to the aggressiveness of cancer cells. In this region, the resilience of the cancer
cure equilibrium P0 plays an important role. The survival and installation of a tumor mass
depend on factors which favor the mutations from normal to cancer cells, such as increased
genetic instability and/or exposure to external carcinogenic agents [36]. These factors can lead
to an increase in the initial conditions of cancer cells and allow them to surpass the threshold
separating the basins of attraction of P0 and P2 (see Figure 2 left). Therefore, it is important to
analyze how the resilience of P0 behave as key parameters are changed. In the next Section we
develop this ‘resilience analysis’. We refer to [14] for a model that comprises an intermediary
pre-cancer population that continuously ‘feed’ the population A with new individuals.
Finally, case III represents a dramatic corruption of the repair system, β3 < βth3 . Now, the
cancer equilibrium P2 is globally stable, and the onset and development of cancer are possible
for any initial number of cancer cells. However, distinct quantitative behaviors may be observed,
depending on the initial number of cancer cells. In Figure 2 we see that the time at which the
tumor reaches a detectable size (approximately 106 cells [37]) is more than ten years if a single
mutant cell arises. As the number of initial cancer cells increases, this time decreases.
We present in Figure 3 bifurcation diagrams when β3 and β1 vary. When β3 varies with
β1 fixed, two different cases occur (Figure 3, top panels). In the case i), the tumor is not
much aggressive to normal cells, β1 < βth1 , and we have a transition between regimes I and
III through a transcritical bifurcation. In case ii), the tumor is very aggressive, β1 > βth1 ,
and we have transitions from regimes I to II (saddle-node bifurcation) and from II to III
(transcritical bifurcation). Before entering in regime III, there is a previous and additional
interval, βth3 < β3 < βth3,∆ that allows cancer onset depending on initial conditions (regime II).
The comparison of cases (i) and (ii) contributes to the debate of whether intrinsic or extrinsic
factors are the major responsible for cancer onset [11, 10]. Due to the possibility of a direct
transition from regime I to II when β1 > βth1 , we conclude that extrinsic factors appear to be
the major cause of aggressive tumors, but combined with small contribution of intrinsic factors
(β3 < βth3,∆). On the other hand, the possibility of direct transition from I to III in case (i)
implies that non-aggressive tumors may arise due to intrinsic factors only.
When β1 varies while β3 is kept constant, we have a different effect (Figure 3, bottom
panels). In the case when the tissue response to tumor is low, β3 < βth3 , no bifurcation occurs
and we remain in regime III for all β1. In the second case, the tissue response is high, β3 > βth3 ,
and a transition between regimes I and II occurs through a saddle-node bifurcation. We remain
in regime II for all values of β1 > βth1,∆, and no transition to regime III occurs, on the contrary
to case (b) when β3 varies with a high aggressiveness of tumor. Comparison of diagrams
(ii) and (b) lead to an interesting conclusion. While normal cells are able with their own
characteristics (strong repair system) to guarantee tissue integrity against aggressive tumors,
aggressive cancer cells, on the other hand, depend on genetic instability (initial conditions)
when fighting aggressive normal cells.
4.2 Cancer treatment as an attempt to allow a critical transition
Now, let us consider cancer treatment. We focus on application of chemotherapy due to its
wide use, but some of the general results may be extended to other types of treatment, like
radiotherapy or surgery. A simple way to include chemotherapy in system (1) is to consider
9
Figure 3: Top: bifurcation diagrams of coordinate A of equilibrium points when β3 varies,
with β1 < βth1 (left), and β1 > βth1 (right). Down: bifurcation diagrams when β1 varies, with
β3 < β
th
3 (left), and β3 > βth3 (right). Continuous plot corresponds to stable equilibrium,
while dashed plot corresponds to unstable equilibrium. These diagrams are particular cases
(horizontal sections i and ii and vertical sections a and b) of the bidimensional one, shown in
Figure 1.
the following equations:
dN
dt
= rN − µNN − β1NA− αNγNND (7a)
dA
dt
= rAA
(
1− A
KA
)
− (µA + A)A− β3NA− αAγAAD (7b)
dD
dt
= v(t)− γNND − γAAD − τD. (7c)
Here, D is the chemotherapeutic drug. It is administered according to a treatment function v(t),
and has a clearance rate τ . The terms γNND and γAAD describe drug absorption by normal
and cancer cells, while the killing terms αAγAAD and αNγNND follow the log-kill hypotheses.
This is based on an analogy with the mass action law, and states that the exposure to a given
amount of drug kills a constant fraction of the cell population [13]. The treatment function can
be described as a finite sum of Dirac Deltas,
v(t) =
n∑
i=1
ρδ(t− iT ),
which represents n doses of ρ mg of drug each, each T days. Figures 4 and 5 show simulations
of system (7) in cases II and III respectively. In these simulations, we assumed the values
τ = 2.5 day−1, γA = 0.3 × 10−8 cell−1day−1, and αA = 0.5 × 108 cell mg−1 and γN = 0.6γA
and αN = 0.6αA, since the chemotherapeutic agent is supposed to be more specific to cancer
cells than normal cells. The values for γA and αA were taken arbitrarily, but with a order of
magnitude coherent with other parameters and with the expected behavior for system (7). The
treatment parameters were ρ = 10 mg, T = 7 days, and n = 4, 5, 6, 7 doses.
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Figure 4: Solutions of system (7) when parameters correspond to regime II, with the number
of doses given by n = 4 (continuous), n = 5 (dashed), n = 6 (dot-dashed) and n = 7 (dotted).
Initial conditions were (A(0), N(0)) = P2, representing that the treatment was initiated only
after the tumor reached the steady state P2. In panel (A), the small black (large blue) numbers
on phase portrait indicate the time in months (weeks) in which the solution was at each point.
In panels (A) and (B) the gray dotted curve represents the separatrix between the basins of
attraction of P0 and P2.
More important than the form used to modeling the treatment v(t), the general property
is that all chemotherapeutic treatments cease after some time tf > 0, i.e., v(t) = 0 for all
t > tf . Thus, D(t) ≤ −τD and so D → 0 when t → ∞. Therefore all solutions of system (7)
approach solutions of system (1) when t → ∞. This fact have an important consequence in
our ecological perspective. In the real system underlying tumor growth, the treatment would
have only the effect of state space disturbance, without altering the intrinsic dynamics. This
important feature reveals that the possibility of cure, above all, concerns questions of stability
and resilience. Figures 4 and 5 provide an illustration of this fact.
If tumor growth in a patient is described by some underlying dynamical system which does
not have a cancer cure stable equilibrium, then a complete cure is not possible. This is what
happens in case III, due to the weakness of the repair system, and it is illustrated in Figure 5.
After getting near this equilibrium through the treatment, the system moves back to the cancer
equilibrium, even if it takes a long time. Thus, it is necessary a systemic change that alters the
dynamics permanently. However, as also shown in Figure 5, even in this regime of instability of
the cure equilibrium, treatment may lead to large time survival. Indeed, the closer the system
approaches the cure equilibrium, the longer it takes to tumor recurrence be observable. This
fact is related with the large time necessary to pass through a saddle-point.
On the other hand, even if the system has a cancer cure stable equilibrium, as in case II here,
the treatment may be ineffective if the solution does not achieve the basin of attraction of the
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Figure 5: Solutions of system (7) when parameters correspond to regime III, with the number
of doses given by n = 4 (continuous), n = 5 (dashed), n = 6 (dot-dashed) and n = 7 (dotted).
Initial conditions were (A(0), N(0)) = P2, representing that the treatment was initiated only
after the tumor reached the steady state P2. In panel (A), the small black (large blue) numbers
on phase portrait indicate the time in months (weeks) in which the solution was at each point.
cure equilibrium. It is the case of simulation with n = 4 in case II, shown in Figure 4. In other
words: a necessary condition to a treatment be effective is that the underlying system must
have a stable cancer cure equilibrium; and the sufficient condition for the treatment be effective
is that the treatment must move the trajectory to the basin of attraction of this equilibrium
(simulations with n = 5, 6, 7 in case II). Once it has been reached, the treatment can stop,
since the patient own repair system will eliminate the reminiscent cancer cells, and move the
trajectory in direction to the cure equilibrium. Thus, the resilience of cancer equilibrium plays
an important role: if this equilibrium has a large and deep basin, and is located at a large
distance from the basin boundary, then more doses, or more intense doses, will be necessary
in order to make the treatment to be effective. Further, it also suggests a mechanism through
which two individuals with similar diagnosis and treatments may have different fates: some
of those treatments which end very near the separatrix (simulation with n = 5 in Figure 4)
may become ineffective due to stochastic fluctuations which can drive the system to the cancer
basin again, while other may continue in the cure basin. This indicates that truly effective
treatments should drive the system to a safe distance from the boundary of the basin. This
rationale agrees with the fact that treatments which consist of single surgery or radiotherapy
(which would correspond to large state space disturbances) must be reinforced by subsequent
adjuvant treatment in order to preclude tumor relapse [38].
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5 Resilience Analysis
The ecological point of view on cancer discussed above is illustrated through the stability
landscape in Figure 6. In this stability landscape, the creation of the cancer equilibrium and
the loss of stability by the cancer cure equilibrium (large red and orange arrows) is achieved
by the sequential acquiring of genetic alterations that improve the fitness of cancer cells (the
hallmarks of cancer [9]), both by deregulating mechanisms of control or by creating mechanisms
which favor cancer cell functions. The transition from I to III (large orange arrow) occurs only
if tumor aggressiveness is low. Destruction of cancer equilibrium and creation of stability of the
cancer cure equilibrium (opposite directions of large red and orange arrows) will be achieved
only by a permanent change in the intrinsic system, through, for instance, restoring the control
systems (immunostimulation for example) or by limiting cancer cells functions (continuous anti-
angiogenic treatments for example, which would decrease the value of KA in theory). Finally,
combination of small changes in parameters with perturbations on state variables also have a
fundamental role, since the former can diminish the basin of attraction while the latter push
the system to cross the basin boundary.
Regime I Regime III
Regime II Regime II
Figure 6: An ecological view on cancer onset and treatment as the switching between two
states, a cancer cure state (positions of blue balls) and a cancer state (positions of red balls).
Perturbations on state variables are due to exposure to external carcinogenic factors and genetic
instability (small red arrows), which favor the moving in the direction to the cancer state, or to
chemotherapy, radiotherapy and surgery (small blue arrows), which move the system towards
the cancer cure equilibrium. Perturbations in parameters (large arrows) lead to transitions
between the three different regimes (I, II and III), and may create or destroy equilibria, or lead
to changes of stability in these equilibria, what can makes impossible either the cure or the
onset of cancer.
Let us analyze the effect of parameters changes on the resilience of stable equilibria of
system (1), i.e., on size and shape of their basins of attraction. To perform this analysis we
briefly review the measurements which may be of importance when analyzing the resilience of
13
an equilibrium [8, 6, 7, 5]. As far as we know, very few papers have dealt with this kind of
analysis for population dynamics models [8, 27, 28], although it is not an uncommon approach
for systems modeling power grids [5]. Recently, Mitra et al. applied these measures to the
nonlinear pendulum, the daisy-world model, and to an one-dimensional model of desertification
in Amazon forest [8]. Also, as far as we know, the methods provided here to calculate these
measures are novel and more efficient than the currently used ones, which consist in integrating
the system in many points of the phase space, assigning each point to some basin of attraction.
Throughout this section, we represent a point with coordinates N and A by X = (N,A).
5.1 The latitude L(P ) of an equilibrium point
The latitude of an equilibrium point corresponds to the volume of the basin of attraction.
It measures the resilience of that equilibrium with respect to state-space perturbations. The
larger the latitude of an equilibrium, the smaller is the chance that external or probabilistic
events will drive the system outside the basin of attraction. For two dimensional systems, the
latitude corresponds to the area of the basin of attraction. However, as it may happen that the
basin of attraction has infinite area, it may be the case to consider its area inside a relevant
bounded region. In the case of system (1), all trajectories remain in the box B given in (6).
This box could be this bounded region of interest. However, biological relevant perturbations
of P2 = (N2, A2) will diminish the value of both coordinates, and relevant perturbations of
P0 = (rN/µN , 0) will diminish the first coordinate and increase the second one. Thus, we
consider the smallest box C which contains P0 and P2 as our bounded region of interest. It is
clear that
C = [0, rN/µN ]× [0, A2].
Thus, if A(P ) denotes the basin of attraction of P , then the latitude of P in our case is defined
by
L(P ) =
Area (A(P ) ∩ C)
Area (C)
. (8)
We divide by the total area of C to obtain a non-dimensional quantity normalized between 0
and 1. In the case when system presents bistability (region II of parameters space) it is clear
that
L(P0) + L(P2) = 1.
Extreme cases are regions I and III. In region I, when P0 is globally stable, we have
L(P0) = 1, L(P2) = 0,
In region III, when P2 is globally stable,
L(P0) = 0, L(P2) = 1.
We present a simple and efficient method to calculate L(P ) for two dimensional systems. It
consists of two steps. The first step is to obtain the terms of a series expansion for a parametric
representation for the stable manifold of saddle point in a two-dimensional system. The second
step involves the use of Green’s Theorem to transform the area of the basin of attraction in a
line integral calculated along the stable manifold approximated in the first step.
Summary of first step Let X∗ be a saddle point of the two-dimensional system
X ′ = F (X), X ∈ R2,
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where F is a C1 vector field. In the vicinity of X∗, this system can be re-written as
X ′ = J(X −X∗) +G(X),
where G(X) = O(||X − X∗||2) and J = F ′(X∗) is the Jacobian matrix evaluated at X∗. Let
J = MKM−1 its Jordan decomposition, with
K =
[
k11 0
0 k22
]
,
where k11 and k22 are the eigenvalues of J and satisfy k11 < 0 < k22, since X∗ is a saddle-point.
With the change of coordinates
U = M−1(X −X∗),
the previous system becomes
U ′ = KU +R(U),
where R(U) = M−1G(X∗ + MU) = O(||U ||2). This system can be written in coordinates
U = (u, v) as
u′ = f(u, v), v′ = g(u, v).
The origin is a saddle point for this system. Its stable manifold is tangent to v = 0, and is
locally the graph of a function v = p(u). Substituting it into v′ = g(u, v) we obtain a nonlinear
ODE for p(u):
p′(u)f(u, p(u)) = g(u, p(u)).
Although this ODE cannot be solved in general, we can write a series expansion
p(u) = c2u
2 + c3u
3 + · · ·
and solve term by term, obtaining the coefficients cj recursively. For large k, the truncated
polynomial pk(u) = c2u2 + · · ·+ ckuk provides a good approximation manifold near the origin.
Returning to the original coordinates,
sk(u) = X
∗ +M (u, pk(u))
T
is a parametric approximation of the stable manifold of X∗, for small ||u||.
Summary of the second step Now we explain how to calculate
L(P ) =
Area (A(P ) ∩ C)
Area (C)
=
∫∫
A(P )∩C dAdN∫∫
C
dAdN
. (9)
The infinitesimal area element is denoted by dAdN . The integral in the denominator is easy to
calculate in general; in our case C is a rectangle. The difficulty lies in calculating the integral
in the numerator. However, it can be easily calculated by using the approximation of the stable
manifold obtained in the previous step and Green’s Theorem. Indeed, the boundary of the
region R = A(P ) ∩ C is formed by four curves, ∂R = S ∪ L1 ∪ L2 ∪ L3, where S is the part
of the stable manifold of P1 which is contained in C, and Li, i = 1, 2, 3, are line segments
contained in the boundary of C. By Greens’ Theorem, the integral can be written as∫∫
A(P )∩C
dAdN =
∮
∂R
NdA =
∫
S
NdA+
3∑
i=1
∫
Li
NdA,
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with the correct orientation defined for these curves. The summation terms are easily computed,
and a good approximation for the integral in S is given by using the parametric approximation
obtained in the first step. With this approach, we have a very good approximation of L(P ).
Let us comment on the applicability of this method. First of all, the method works when
the separatrix is formed by invariant manifolds of saddle points [39]. If many saddle points lie in
the boundary, then the first step needs to be applied to each point. Second, the bounded region
C must be such that its area is easily calculated. These first two requirements are very general
[39]. The last and most restrictive condition is that, for each saddle point in the separatrix,
the local approximation obtained in the first step must be a good approximation at all points
inside C. The method fails when this requirement is not satisfied. In our case, for parameters
values in Table 1, the approximation for the stable manifold of P1 with 25 terms was obtained
in a few seconds by Mathematica c©, and provided a very good approximation for points inside
C. The separatrix in Figures 2, 4 and 7 was plotted with this approximation.
5.2 The precariousness Pr(P ) of an equilibrium point
Another important measure is the precariousness of an equilibrium point. Roughly speaking,
it is defined as the minimum perturbation required to drive the system to another basin of
attraction. As a basin of attraction of interest may be large but the equilibrium may be located
near the boundary, the precariousness is an important measure. It can be defined as
Pr(P ) = inf{dist(P,X), X ∈ ∂A(P )},
where ∂Ω stands for the boundary of the set Ω, and dist(X, Y ) is the Euclidean distance.
However, it may happen that perturbations of relevance may not occur in the direction where
this minimum distance is achieved. Thus, one can consider
Pr(P ) = inf{dist(P,X), X ∈ ∂A(P ) ∩ Z(P )},
where Z(P ) is a specified set containing the relevant directions for perturbations from P [6].
For system (1), all relevant perturbations of P2 will diminish both coordinates. Thus we define
Pr(P2) = inf{dist(P2, X), X ∈ ∂A(P2) ∩ Z(P2)}, Z(P2) = [0, N2]× [0, A2]. (10)
Let us now consider which are the relevant perturbations of P0. As new cancer cells may arise
in the tissue, we may consider perturbations which increase the value of A. Thus, it would be
the case to consider a single direction, ~v1 = (0, 1). However, as cancer cells arise during mitosis,
roughly speaking, the number of normal cells diminish by one when a cancer cell arises. Thus,
it would be the case to consider the direction given by ~v2 = (−1, 1). Therefore, we consider all
directions between ~v1 and ~v2, giving us the set above the line N + A = rN/µN (which passes
through P0 and is parallel to ~v2) and to the left of the vertical line N = rN/µN (which passes
through P0 and is parallel to ~v1). Thus, the expression of Z(P0) is
Z(P0) = {(N,A) ∈ R2+, N + A ≥ rN/µN , N ≤ rN/µN}.
An illustration of regions Z(P0) and Z(P2) can be seen in Figure 7.
In extreme cases I and III we do not have bistability, and Pr(P ) must be defined ap-
propriately. In case III, when P2 is globally stable, we define Pr(P2) as the tumor volume,
Pr(P2) = A2, meaning that the removal of the entire tumor leads the system outside the basin
of attraction of P2. Indeed, this removal leads the system to the N -axis, which is the invariant
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Figure 7: Phase portrait of system (1). Z(P2) is the box with P2 in one of the vertices. Z(P0) is
the triangular region with P0 in its vertices. The blue points are the nearest points of P0 and P2
inside regions Z(P0) and Z(P2) respectively. The intensity of color on background correspond
to the value of the local resistance R(N,A) defined in sub-section 5.3.
manifold of P0. Analogously, in case I, when P0 is globally stable, we define Pr(P0) = N0.
However, in this case the A-axis is not invariant, and another choice would be Pr(P0) =∞.
The result obtained in the first step of the previous section can be used to calculate the
precariousness of an equilibrium straightforwardly. In our case, let sk(u) = (s1k(u), s2k(u)) be
the approximation for the stable manifold of P1 obtained in that step. To calculate Pr(P0), for
instance, we first find the interval I0 of values of u such that sk(u) ∈ Z(P0). The solution u1 of
equation
s
(1)
k (u1) = rN/µN
is the value of u such that sk(u) lies in the vertical line N = rN/µN . The solution u2 of
s
(1)
k (u2) + s
(2)
k (u2) = rN/µN
is the value of u such that sk(u) lies in the line N + A = rN/µN . Thus, u1 and u2 are the
extrema of interval I0. With this, Pr(P0) is obtained by solving the minimization problem
min ||sn(u)− P0||
u ∈ I0
which can be easily solved. The precariousness of P2 is calculated in an analogous way.
5.3 The resistance R(P ) of an equilibrium point
Finally, the third important measure concerning resilience of an equilibrium is termed as the
resistance of this equilibrium. It refers to “the ease or difficulty of changing the system, related to
the topology of the basin - deep basins of attraction indicate that greater forces or perturbations
are required to change the current state of the system away from the attractor” [7]. Thus, a
resistant system will overcome perturbations rapidly, while a system with small resistance can
be driven to a basin transition through a series of small perturbations that are not absorbed
enough. This description concerns exactly the illustration provided by Figure 4. There, if P2
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is more resistant, more chemotherapeutic doses, or more intense doses, would be necessary to
drive the system to the basin of attraction of P0.
The task of characterizing the sizes and frequencies of perturbations that a basin of attrac-
tion can absorb is currently a research area [6]. Recently, Mitra and others [8] proposed an
approach to measure the resistance of a point in state-space to local pertubations using local
Lyapunov exponents [40]. Again, consider the two-dimensional system
X ′ = F (X),
where F is a C1 vector field. The instantaneous Jacobian matrix at X is defined as
Jdt(X) = I2×2 + J(X)dt,
where J(X) is the Jacobian at X and dt is an infinitesimal time. Let σi(X), i = 1, 2, be
the square roots of the eigenvalues of the right Cauchy-Green tensor Jdt(X)TJdt(X). The
σi(X)’s are also the singular values of Jdt(X). They measure the instantaneous stretching of
the neighborhood of the trajectory at X. The local Lyapunov exponents evaluated at the state
X are defined as
λi(X) =
1
dt
ln (σi(X)) , i = 1, 2,
and measure the rate of stretching at X. The local resistance R(N,A) at the state X = (N,A)
may be defined as
R(X) = −max{λ1(X), λ2(X)}. (11)
Thus, the resistance of an equilibrium point can be measured as
Res(P ) =
∫∫
A(P )∩C R(N,A) dNdA∫∫
C
R(N,A) dNdA
. (12)
The division by the total resistance on C is made to obtain a non-dimensional quantity nor-
malized between 0 and 1.
For system (1), analytical expressions for λi(X), i = 1, 2, at state X = (N,A) can be
calculated using Mathematica c©. The density plot of R(N,A) is showed in Figure 7. With
these expressions, we can calculate integrals in (12). The unique concern is with respect to the
region of integration in the first integral, A(P ) ∩ C. However, this integral can be calculated
using the approximations for the stable manifold of P1 obtained in the first step of Section 5.1.
5.4 Application of resilience analysis to system (1)
We analyze the behavior of the above measures when parameters of system (1) vary. Figure
8 shows the results when β3 varies while other parameters are kept constant, with β1 > βth1 ,
which corresponds to bifurcation diagram (ii) in Figure 3 (center), where a transition I-II-III is
observed. Results when other parameters vary are similar (not shown here).
To discuss these results, we first consider the point of view of cancer onset and analyze the
resilience measures of P0. In region I, P0 is globally stable and all these measures are equal to
the unity. When β3 becomes lesser than βth3,∆ and enters region II, equilibrium P0 is no longer
globally stable, and its resilience measures undergo an abrupt jump and decay rapid in a small
strip near βth3,∆. The most notorious jump occurs with Pr(P0). For values in the midpoint
between the two thresholds separating region II from regions I and III, the values of Pr(P0)
and L(P0) are very small. These features are due to the up-concave shape of the graphs of
L(P0), Pr(P0) and Res(P0), and indicate that in the bistable regime the healthy state P0 is
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Figure 8: Values of L(Pi) (top), Pr(Pi) (center) and Res(Pi) (bottom), i = 0, 2, as β3 varies,
with β1 > βth1 , which corresponds to the bifurcation diagram (ii) in Figure 3 (top, right). As
β3 varies, we observe transitions between regimes III, II and I.
threatened by small disturbances which may easily drive the system to the basin of attraction
of P2.
On the other hand, let us consider the point of view of treatment, and discuss the results
concerning P2. In regime III, this equilibrium is globally stable and L(P2), Pr(P2) and Res(P2)
are equal to the unity. As β3 becomes larger than βth3 , these measures decay very slowly and
are greater than the respective measures of P0, until β3 reaches the small strip near the next
threshold, βth3,∆. Now, these features are due to the down-concave shape of the graphs, and
implicate that P2 is relatively protected against small perturbations.
By comparing these differences on the resilience measures of P0 and P2 we conclude that it
is much more easy to drive the system outside the basin of attraction of the cure equilibrium
P0 when it loses its global stability, than driving the system out of the basin of attraction
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of the cancer equilibrium P2 when it reaches the bistable regime, unless the parameters get
very near the next bifurcation threshold at which P2 loses its stability. In other words, our
analysis reveals that, in the bistable regime, although these are different phenomena, it is more
likely that mutations or exposure to carcinogenic factors drive cancer onset than chemotherapy,
surgery or radiotherapy lead to tumor regression.
5.5 The potential of resilience analysis to personalize cancer treat-
ments
We now illustrate how the resilience analysis can be used to obtain quantitative measures from
models and use them as indicators to design personalized treatments.
Figure 9 illustrates how small differences in parameters lead to differences in the basins sizes
and in the effectiveness of treatments. This Figure shows simulations of system (7) for three
almost identical individuals. The unique difference between them is the tumor apoptosis rate
A. All them are treated with the same drug schedule, which consists in 8 weekly doses of 10mg
each. Patient I has the highest tumor apoptosis rate, A = IA = 1/100 day−1. The treatment
is completely effective since it ends in the ‘cure basin’. Further, there is a very small risk of
tumor relapse, since small perturbations in this trajectory would not be able to drive it again
to the tumor basin. Patient II has a smaller tumor apoptosis rate, A = 0.95IA. The treatment
is effective, but, once it ends very near the separatrix, there is a high risk of tumor relapse.
Finally, patient III has the smallest tumor apoptosis rate A = 0.9IA. The treatment almost
reaches the basin boundary but is not able to cross it. Thus, despite the number of tumor cells
attains a low value at the end of the treatment, tumor relapse is observed after some time.
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Figure 9: Top row: projection of solutions of system (7) in the N × A plane. The small black
(large blue) numbers indicate the time in months (weeks) in which the solution was at each
point. Center and bottom rows: short and long-term dynamics of solutions.
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It is worth to note that the post-treatment situation of all three patients is almost the
same. Indeed, according to the panels in the second and third row of Figure 9, the short term
dynamics is quite similar for all the three patients during a transient period of almost one year.
Only one or two years after the treatment the tumor of patient III starts to exhibit a substantial
difference from the others. This is the same observed in many clinical cases. Once more, these
results suggest that, from this theoretical point of view, those patients who presented tumor
relapse could be completely cured if they were treated with a more intense drug schedule, which
could be previously estimated based on some more complete information about them and their
tumors.
The left panel of Figure 10 shows how the latitude and the precariousness of the tumor
basin, together with their product, behave when parameter A varies. We see that the lower is
the tumor apoptosis rate, the higher is the tumor resilience and the more difficult is to reach
the cure basin. The center panel shows how the value of A changes the minimum weekly dose
needed to enable an eight-week treatment cross the boundary. This value varies in a large
range, from 0 mg to 20 mg, 100% with respect to the interval center (10mg), while A varied
in the interval [0.8 × 10−2, 1.05 × 10−2], which is a small relative variation, about ±13% with
respect to the interval center, A = 0.925 × 10−2. All graphs in this Figures 9 and 10 were
obtained with the same parameters values from Table 1, except A. We observe that a small
decrease in A, of 10%, from 0.010 to 0.009, increases this minimum needed dose in 60%, from
7.5 mg to 12 mg. We also see that, in theory, if patient III receive a 12 instead of a 10 mg of
drug dose each week, he would be cured. In case of toxicity constraints, an additional week of
treatment would result in the same effect. Finally, the panel on the right shows the relationship
between the ‘tumor resilience’ (values of latitude × longitude) and the minimal needed dose.
Despite being obtained with a simple model for tumor growth which does not consider
several important interactions in the tumor microenvironment, the results above show the
potential of this kind of ‘resilience analysis‘ as a method to obtain indicators for design of
tailored treatments design. The application of this approach to a validated model has the
potential to elaborate a computational method to estimate the treatment needs for a particular
patient or, at least, to stratify patients in a more refined fashion. The method would have as
input data taken from the patient’s tumor (its growth data obtained in vivo or in vitro). Then,
a black-box function would calculate the total resilience of that tumor. This output would be
used to prescribe a tailored treatment protocol which would be, in theory, effective to reach the
cure of that patient. The resilience approach was already applied to several other areas, but,
as far as we know, this work is the first to do this for cancer.
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Figure 10: Left: the behavior of resilience measures as A varies. Center and right: behavior of
the minimum weekly dose needed to enable an eight-week treatment to cross the boundary, as
a function of A (center) and the tumor resilience latitude × longitude (right).
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6 Conclusion
In this paper, an ecological resilience framework to think of cancer as the alternance between
two states was presented. This framework was based on the analysis of a simple ODE model
for tumor growth considering the interaction with the host tissue. Despite the simplicity of the
model, the approach adopted here gives interesting theoretical insights that shed some light on
several relevant issues concerning cancer onset and treatment, and may help to improve the
way we view cancer.
The model exhibited three regimes. These regimes were used to illustrate three different
possibilities which may occur in clinical cases in general. The first regime corresponds to
a healthy person where cancer onset is not possible since the cancer cure state is globally
stable. The second regime corresponds to a person which can develop cancer if exposed to
external carcinogenic factors, due to a partially corrupted repair system and/or a high aggressive
phenotype of tumor cells. This regime presents bistability between the cancer and the cancer
cure states. The third regime corresponds to a person in which cancer will arise due to intrinsic
factors, i.e., the total corruption of repair systems. In this regime, the cancer state is globally
stable.
Based on the general property that treatments are finite and, therefore, do not change
the global dynamics in the phase space, we discussed the possibility of cure, which concerns
stability and resilience questions above all. In the bistable regime the cure is possible if the
treatment is able to drive the system to the basin of attraction of the cure equilibrium. Tumor
recurrence in this case is associated with treatments which are unable to cross the separatrix
between the basins, or which do not end at a safe distance from the separatrix. In the third
regime, the complete cure is not possible at all, since the repair system is intrinsically weak,
but tumor recurrence may be delayed if the treatment is prolonged, because the system takes a
long time to pass around the cure equilibrium, which is a saddle point. However, toxicity was
not assessed in this model.
Besides perturbations on state variables, a view in the switching between these three regimes
due to parameters changes in a slow time scale was discussed and the roles of the most important
parameters in these transitions were assessed. Results indicated that only aggressive tumors
may arise if intrinsic repair systems are not totally corrupted. Further, these aggressive tumors
depend on exposure to external carcinogenic factors for arising.
Finally, we reviewed the use of three different measures to assess the resilience of a stable
equilibrium. We proposed a simple and efficient methods to calculate these measures. Af-
ter applying this analysis to the model we concluded that in the bistable regime the cancer
equilibrium has much more resilience than the cure equilibrium, with respect to state variable
perturbations as parameters changes. We also illustrated how resilience analysis can be used
to estimate the treatment needs for a particular patient, and showed its potential to design
personalized cancer treatments.
This paper contributes to the current understanding on cancer by raising some issues in an
ecological view, and also demonstrates how a ‘resilience analysis’ may be applied to population
dynamics models in order to improve the understanding of nonlinear phenomena. Further, the
application of the ‘resilience analysis’ presented here to detailed and accurate models for specific
tumor types has the potential to generate measures which can be accounted for in the design
of treatment plans for cancer patients and also in the development of adaptive treatments [13].
The size and shape of the basin of attraction of the cancer equilibria in those models may be
used as indicators in the design and planning of personalized treatments.
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